Literature DB >> 2114693

DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study of formalin-fixed paraffin-embedded tissue.

H Baisch1, G Klöppel, B Reinke.   

Abstract

The cellular DNA content of formalin-fixed, paraffin-embedded specimens from 47 ductal adenocarcinomas of the pancreas and 5 adenocarcinomas of the ampulla of Vater was analysed using flow cytometry. Ploidy and the fraction of cells in the S and G2M phases were determined and correlated with tumour stage and grade as well as patients' survival. Cell populations with aneuploid DNA content were observed in 15% of the tumours. The S + G2M fractions ranged between 1% and 10%. Compared to non-neoplastic tissue of the pancreas the S + G2M fraction was significantly higher in the carcinomas. Cox regression analysis revealed the S + G2M fraction as an independent prognostic factor (p less than 0.05). Ploidy was of no prognostic value for survival, but correlated weakly with tumour stage and tumour grade. All patients without lymph node metastases at time of surgery had diploid tumours. Aneuploidy was restricted to tumours in advanced stages and tended to be more frequent in high-grade tumours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114693     DOI: 10.1007/bf02190532

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

1.  [Fluorescent staining of mammalian chromosomes with a basically substituted bis-benzimidazole derivative (preparation 33258 "Hoechst")].

Authors:  A Herzog; H R Schütze
Journal:  Dtsch Tierarztl Wochenschr       Date:  1968-10-01

2.  [New aspects of pancreatic carcinoma (author's transl)].

Authors:  G Klöppel; J Sosnowski; H P Eichfuss; K Rückert; R Klapdor
Journal:  Dtsch Med Wochenschr       Date:  1979-12-21       Impact factor: 0.628

3.  Ploidy as prognostic determinant in pancreatic cancer.

Authors:  A R Weger; A H Graf; U Askensten; G Schwab; E Bodner; G Auer; G Mikuz
Journal:  Lancet       Date:  1987-10-31       Impact factor: 79.321

4.  Attempted curative resection of ductal carcinoma of the pancreas: review of Mayo Clinic experience, 1951-1975.

Authors:  A J Edis; P D Kiernan; W F Taylor
Journal:  Mayo Clin Proc       Date:  1980-09       Impact factor: 7.616

5.  Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.

Authors:  T S Johnson; K D Williamson; M M Cramer; L J Peters
Journal:  Cytometry       Date:  1985-09

6.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

7.  [Morphologic criteria of the growth behavior of pancreatic cancers. Experimental and clinico-pathologic studies].

Authors:  G Klöppel; G Lingenthal; R Klapdor; H F Kern; K Rückert; M von Bülow
Journal:  Dtsch Med Wochenschr       Date:  1984-05-04       Impact factor: 0.628

8.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

9.  Evaluation of flow cytometric data of human tumours. Correction procedures for background and cell aggregations.

Authors:  H P Beck
Journal:  Cell Tissue Kinet       Date:  1980-03

10.  Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.

Authors:  O S Frankfurt; H K Slocum; Y M Rustum; S G Arbuck; Z P Pavelic; N Petrelli; R P Huben; E J Pontes; W R Greco
Journal:  Cytometry       Date:  1984-01
View more
  5 in total

1.  Implications of malignant-cell DNA content for treatment of patients with pancreatic cancer.

Authors:  A L Warshaw
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

2.  DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study of formalin-fixed paraffin-embedded tissue.

Authors:  K A Alanen; H Joensuu; P J Klemi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas.

Authors:  S Linder; J Lindholm; U Falkmer; M Blåsjö; P Sundelin; A von Rosen
Journal:  Int J Pancreatol       Date:  1995-12

4.  DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.

Authors:  S Sciallero; W Giaretti; E Geido; L Bonelli; L Zhankui; S Saccomanno; E Zeraschi; V Pugliese
Journal:  Int J Pancreatol       Date:  1993-08

5.  Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.

Authors:  Nikolas Tsavaris; Nicolaos Kavantzas; Kostantinos Tsigritis; Ioannis D Xynos; Nikitas Papadoniou; Andreas Lazaris; Christos Kosmas; George Agrogiannis; Anna Dokou; Evangelos Felekouras; Efstathios Antoniou; Aris Polyzos; John Sarantonis; Heracles Tsipras; Gavrilos Karatzas; Alexandros Papalambros; Efstratios S Patsouris
Journal:  BMC Cancer       Date:  2009-07-31       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.